Cortactin-Src Kinase Signaling Pathway Is Involved in N-syndecan-dependent Neurite Outgrowth by Kinnunen, Tarja et al.
Cortactin-Src Kinase Signaling Pathway Is Involved in
N-syndecan-dependent Neurite Outgrowth*
(Received for publication, August 12, 1997, and in revised form, January 13, 1998)
Tarja Kinnunen‡§¶i, Marko Kaksonen‡§¶, Juhani Saarinen**, Nisse Kalkkinen**,
H. Benjamin Peng‡‡, and Heikki Rauvala‡§
From the ‡Laboratory of Molecular Neurobiology, Institute of Biotechnology, §Department of Biosciences, Division of
Biochemistry, **Protein Chemistry Laboratory, Institute of Biotechnology, University of Helsinki, P. O. Box 56, 00014
Helsinki, Finland and the ‡‡Department of Cell Biology and Anatomy, University of North Carolina, Chapel Hill,
North Carolina 27599
N-syndecan (syndecan-3) was previously isolated as a
cell surface receptor for heparin-binding growth-associ-
ated molecule (HB-GAM) and suggested to mediate the
neurite growth-promoting signal from cell matrix-
bound HB-GAM to the cytoskeleton of neurites. How-
ever, it is unclear whether N-syndecan would possess
independent signaling capacity in neurite growth or in
related cell differentiation phenomena. In the present
study, we have transfected N18 neuroblastoma cells
with a rat N-syndecan cDNA and show that N-syndecan
transfection clearly enhances HB-GAM-dependent neu-
rite growth and that the transfected N-syndecan distrib-
utes to the growth cones and the filopodia of the neu-
rites. The N-syndecan-dependent neurite outgrowth is
inhibited by the tyrosine kinase inhibitors herbimycin A
and PP1. Biochemical studies show that a kinase activ-
ity, together with its substrate(s), binds specifically to
the cytosolic moiety of N-syndecan immobilized to an
affinity column. Western blotting reveals both c-Src and
Fyn in the active fractions. In addition, cortactin, tubu-
lin, and a 30-kDa protein are identified in the kinase-
active fractions that bind to the cytosolic moiety of N-
syndecan. Ligation of N-syndecan in the transfected
cells by HB-GAM increases phosphorylation of c-Src and
cortactin. We suggest that N-syndecan binds a protein
complex containing Src family tyrosine kinases and their
substrates and that N-syndecan acts as a neurite out-
growth receptor via the Src kinase-cortactin pathway.
HB-GAM1 was initially isolated from neonatal rat brain as a
neurite outgrowth-promoting protein, the expression of which
in brain corresponds to the stage of rapid axonal growth (1).
Molecular cloning of full-length cDNA identified a novel secre-
tory sequence (2). The same cDNA sequence was reported for
pleiotrophin, a protein suggested to be mitogen for fibroblastic
cells (3, 4). The HB-GAM/pleiotrophin sequence shares approx-
imately 50% homology with the midkine protein involved in
retinoic acid-induced cell differentiation (5–7).
The expression of HB-GAM in the axon pathways of the
brain and in the basement membranes outside of brain (8–9)
and the neurite outgrowth-promoting property of HB-GAM in
vitro (see Refs. 1 and 4) have suggested interaction of matrix-
associated HB-GAM with a cell surface receptor. Furthermore,
HB-GAM is expressed at the surface of developing muscle cells
and is suggested to play a role in the development of nerve/
muscle contacts (10–12).
N-syndecan (syndecan-3) has recently been isolated from
detergent extracts of perinatal rat brain as a receptor or co-
receptor for HB-GAM using recombinant HB-GAM as an affin-
ity matrix (13). N-syndecan is localized at the surface of neu-
rites and their growth cones in rat primary neurons growing on
HB-GAM-coated matrix in vitro (13). Furthermore, HB-GAM
and N-syndecan are spatiotemporally co-expressed in develop-
ing rat brain (14).
The cell surface N-syndecan interacts with HB-GAM
through its heparan sulfate chains (15). This interaction is
enhanced by assembly of the heparan sulfates in the protein
moiety and is specific, as soluble N-syndecan and N-syndecan-
derived glycosaminoglycans, in contrast to several other glycos-
aminoglycans, inhibit HB-GAM-induced neurite outgrowth in
vitro (15). Anti-N-syndecan antibodies also inhibit specifically
the interaction of HB-GAM with brain neurons (13).
N-syndecan is a member of the syndecan gene family of
transmembrane heparan sulfate proteoglycans that are ex-
pressed in cell- and development-specific patterns (16). The
four syndecans (syndecan-1, -2, -3, and -4) have structurally
variable extracellular domains, but a high degree of conserva-
tion is found on their cytoplasmic domains (for reviews, see
Refs. 17–20). The highly conserved cytoplasmic domain sug-
gests an important function for it. This could occur either by
association of syndecans directly with the cytoskeleton or with
second messenger pathways. The core protein of syndecan-1
has been shown to colocalize with actin in syndecan-1-trans-
fected Schwann cells (21), and syndecan-4 has been shown to
localize to focal contacts (22).
The functions of cell surface proteoglycans and their inter-
actions with the extracellular matrix have been widely studied
(for reviews, see Refs. 23–25). In this paper, we study the
HB-GAM-induced signals mediated by N-syndecan to the cyto-
plasm. We have transfected N18 neuroblastoma cells with an
N-syndecan cDNA and show that cells expressing N-syndecan
respond to HB-GAM by growing neurites, whereas the parental
cells or mock-transfected cells respond weakly if at all. We have
purified proteins from detergent extracts of rat brain and show
that kinase activity together with substrate(s) associates with
the N-syndecan cytosolic domain. Biochemical studies show
that a protein complex containing Src family kinases (c-Src and
Fyn) and their substrate(s) binds to N-syndecan. Cell-biological
studies show that phosphorylation of both c-Src and cortactin is
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increased when N-syndecan is ligated by HB-GAM. We suggest
that N-syndecan associates with the Src-cortactin pathway and
thus mediates neurite outgrowth induced by extracellular
matrix-bound HB-GAM.
EXPERIMENTAL PROCEDURES
Cloning of N-syndecan cDNA and Construction of an N-syndecan
Expression Vector—N-syndecan cDNA was isolated from a rat hip-
pocampal cDNA library (Stratagene), using a fragment of N-syndecan
cDNA produced by polymerase chain reaction as a probe (14). A cDNA
of 5.5 kilobases was isolated and confirmed by sequencing to correspond
to an N-syndecan sequence (26). A 1.8-kilobase EcoRI-XhoI restriction
fragment containing a 47-base pair leader, the complete 1329-base pair
coding sequence, and a 419-base pair 39-untranslated region was li-
gated into the pHbA-pr1-neo vector (27), which was cut with EcoRI and
XhoI restriction enzymes. pHbA-pr1-neo contains human b-actin pro-
moter, which drives a strong ubiquitous expression and a neomycin
resistance gene.
Transfection of N18 Neuroblastoma Cells—N18 cells were grown in
Dulbecco’s modified Eagle’s medium 1 10% fetal calf serum. The cells
were transfected by lipofection using Transfectam reagent (IBF Bio-
technics). G418 (600 mg/ml; Life Technologies, Inc.) was added to the
medium after 48 h to select for stably transfected clones. Individual
G418-resistant clones were picked and screened for N-syndecan expres-
sion by Northern blotting as described (14) using the 1.8-kilobase N-
syndecan cDNA as a probe. Two clones having the highest level of
expression were chosen for further study. Control cells were transfected
with vector only, and two G418-resistant clones were chosen randomly.
N-syndecan-transfected and mock-transfected clones have been cul-
tured under identical conditions.
Neurite Outgrowth Assays—Subconfluent N18 cultures were used for
neurite outgrowth assay. Assays were done essentially as described
before (28). Cells were detached by incubation in phosphate-buffered
saline for 15 min followed by vigorous pipeting with a Pasteur pipette.
Microtiter wells were coated by incubating with HB-GAM solution (5
mg/ml) for 20 h at 14 °C. Cells were plated on HB-GAM-coated wells
(5 3 103 cells/well) and grown in serum-free Dulbecco’s modified Eagle’s
medium containing 10 mg/ml bovine serum albumin for 24 h and fixed
with 2% glutaraldehyde for 30 min. Proportion of neurite-bearing cells
was counted with inverted microscope using phase contrast. Cell proc-
esses longer than two cell diameters were counted as neurites. For
microphotography, the cells were seeded on microscope coverslips
coated with HB-GAM.
Immunocytochemistry—Cells were grown on coverslips as in neurite
outgrowth assays for 24 h. They were fixed with 4% paraformaldehyde
and blocked with 10% fetal calf serum in phosphate-buffered saline for
1 h. Cells were incubated with polyclonal anti-N-syndecan antibodies (5
mg/ml; Ref. 14) for 1 h at room temperature in blocking solution. Bind-
ing of the antibodies was detected with TRITC-labeled goat anti-rabbit
antibodies (Jackson ImmunoResearch Laboratories, Inc.). Olympus Pro-
vis 70 microscope with a 60 3 apochromat objective was used for micros-
copy. Micrographs were taken using a Photometrics SenSys CCD camera.
Isolation of N-syndecan Binding Proteins—The peptide correspond-
ing to the cytosolic domain of rat N-syndecan with an N-terminal
cysteine (CRMKKKDEGSYTLEEPKQASVTYQKPDKQEEFYA) was
synthesized using Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemistry
(ABI 433) and purified with high performance liquid chromatography.
Matrix-assisted laser desorption/ionization time-of-flight mass spec-
trometry of the purified peptide confirmed the sequence expected from
the chemical synthesis. The peptide was coupled to Thiopropyl Sepha-
rose 6B (Pharmacia Biotech Inc.) according to the manufacturer’s in-
structions. Residual active groups of thiopropyl-Sepharose were blocked
by reaction with 2-mercaptoethanol at low pH (4.5) at which the ali-
phatic disulfides that link the protein with the gel remain intact.
Forebrains from 4- to 6-day-old rats were homogenized in ice-cold
extraction buffer containing 25 mM Tris-HCl, pH 8.5, 130 mM NaCl, 1%
Nonidet P-40, with 1 mM NaF, 1 mM Na3VO4 as phosphatase inhibitors,
and 1 mM EDTA, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 2
mg/ml aprotinin, 0.6 mg/ml leupeptin, and 0.7 mg/ml pepstatin as pro-
tease inhibitors. The homogenate was extracted for 1 h and centrifuged
at 100,000 3 g for 1 h. The supernatant was precleared with HiTrap
heparin affinity column (Pharmacia) and applied to the peptide affinity
column. The column was washed with 20 column volumes of the extrac-
tion buffer with 0.1% Nonidet P-40, 5 column volumes of the extraction
buffer with 0.1% Nonidet P-40 containing 2% bovine serum albumin,
followed by washing with 5 column volumes of the extraction buffer
with 0.1% Nonidet P-40. The column was further washed with 10
column volumes of each 0.2 M and 0.3 M NaCl. Bound proteins were
eluted with 2.5 column volumes of 1 mg/ml of the peptide corresponding
to full-length cytosolic domain of rat N-syndecan (NS-1). In some ex-
periments, the column was eluted in parallel with a synthetic peptide
corresponding to the membrane proximal region of the syndecan cyto-
solic domain (NS-2, 1 mg/ml, RMKKKDEGSYC; Multiple Peptide Sys-
tems) in the extraction buffer with 0.1% Nonidet P-40. As a control, the
column was eluted with a peptide corresponding to the cytosolic domain
of rat receptor for advanced glycation end products (RAGE, Ref. 29 and
GenBank accession number L33413; CRKRQPRLEERKAPESQEDE-
EERAELNQSEEAEMPENGAGGP). After elution with the peptide, the
column was further washed with 1 and 2 M NaCl. In some experiments,
a blank Sepharose matrix column was run in parallel and analyzed for
binding components.
N-syndecan and coeluting proteins were purified by HB-GAM affin-
ity chromatography as described (13).
Kinase Activity Assays and Immunoprecipitation—Peptide affinity
fractions were concentrated with Microcon microconcentrators (Ami-
con) and dissolved in 100 mM Tris-HCl, pH 7.2, 125 mM MgCl2, 25 mM
MnCl2, 2 mM EGTA, 0.25 mM Na3VO4, 2 mM dithiothreitol. 2 mCi of
[g-32P]ATP (5000 Ci/mmol) in 75 mM MnCl2, 0.5 mM cold ATP was
added to the fractions, and the reaction mixtures were incubated at
30 °C for 10 min. An aliquot of the kinase reaction was diluted with
kinase buffer and immunoprecipitated with anti-cortactin antibodies
(Upstate Biotechnology, Inc.) overnight at 14 °C. The samples were
then incubated with protein G-agarose beads (Sigma) for 3 h at 14 °C.
Agarose beads were collected by centrifugation and washed twice with
the kinase buffer; the bound immunocomplexes were eluted with SDS-
PAGE sample buffer. Samples from the kinase activity assay and im-
munoprecipitations were subjected to SDS-PAGE and autoradiography.
Characterization of Proteins That Bind to the Cytosolic Moiety of
N-syndecan—Proteins of the peptide affinity fractions were separated
on 12% SDS-PAGE, and the proteins of interest were excised from the
gel, cut to 1 3 1-mm pieces, destained, and dehydrated by washing
twice with acetonitrile and dried in a vacuum centrifuge. Proteins were
reduced by rehydrating the gel pieces in 10 mM dithiothreitol in 0.1 M
NH4HCO3 for 30 min at 56 °C. The dithiothreitol solution was removed,
and the proteins were alkylated by addition of 55 mM iodoacetamide in
0.1 M NH4HCO3. Excess iodoacetamide was removed by washing with
0.1 M NH4HCO3, followed by dehydration with acetonitrile, and the
samples were dried in a vacuum centrifuge. The proteins were digested
by rehydrating the gel pieces with 10 ml of lysyl endopeptidase (40
ng/ml) in digestion buffer (0.1 M Tris, pH 9.2, containing 10% acetoni-
trile). Digestion was carried out overnight at 37 °C and stopped by
acidification with trifluoroacetic acid, a final concentration of 1%.
Matrix-assisted laser desorption/ionization time-of-flight mass spec-
trometry was performed in the delayed extraction mode with a BIFLEX
mass spectrometer (Bruker-Franzen Analytik, Germany), using a
337-nm nitrogen laser. A thin layer matrix preparation with saturated
a-cyano-4-hydroxycinnamic acid in acetone was used (30). 0.5 ml of
matrix was deposited on a stainless steel target plate, and 0.5 ml of
sample was added on top of the matrix. External calibration was per-
formed with angiotensin 2 and ACTH clip (Sigma).
For N-terminal sequence analysis, the peptides were extracted from
the gel pieces with two 30-min washes with 0.1% trifluoroacetic acid in
60% acetonitrile and concentrated in a vacuum centrifuge. Extracted
peptides were separated by reversed-phase chromatography using
LCPackings 1 3 150-mm C8 column (packed with Vydac C8 300 Å,
5-mm material) on Pharmacia SMART system with a trifluoroacetic
acid-acetonitrile solvent system. N-terminal sequence analysis was per-
formed with an Applied Biosystems PROCISE494 sequencer.
Immunoblotting—Fractions eluted from the N-syndecan peptide col-
umn were separated on 10–20% SDS-PAGE and transferred to nitro-
cellulose filters. Immunoblotting was done essentially as described (1)
using horseradish peroxidase-conjugated secondary antibodies detected
with enhanced chemiluminescence (Amersham). Monoclonal antibody
against cortactin, 4F11 (anti-p80/85), and monoclonal antibody to c-Src,
GD11, were from Upstate Biotechnology Inc. Monoclonal antibody to
Fyn (FYN-15) and polyclonal antibody to c-Src (SRC-2) were from Santa
Cruz Biotechnology, Inc. Monoclonal antibody to class III b-tubulin
(SDL.3DID) was from Sigma. N-syndecan was immunoblotted with
polyclonal N-syndecan antibodies (14) as described (13).
Analysis of Src and Cortactin Phosphorylation—N-syndecan-trans-
fected and mock-transfected N18 cells were cultured on HB-GAM-
coated Petri dishes as described above. At times indicated, the cells
were lysed with extraction buffer (see above) and centrifuged briefly to
remove debris. The supernatant was incubated with anti-phosphoty-
rosine agarose beads (Upstate Biotechnology Inc.) overnight at 14 °C.
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The agarose beads were washed twice with the extraction buffer, and
bound proteins were eluted with SDS-PAGE sample buffer and sub-
jected to gradient SDS-PAGE and immunoblotting.
RESULTS
N-syndecan Transfected to N18 Cells Mediates Tyrosine Ki-
nase-dependent Neurite Outgrowth—N18 mouse neuroblas-
toma cells were transfected with an N-syndecan expression
vector, which contains N-syndecan cDNA under the control of
human b-actin promoter (27). Single G418-resistant clones
were picked, and the level of N-syndecan expression was stud-
ied by Northern hybridization. Two clones (II/7 and II/8) having
the highest expression level were chosen for further analysis
(Fig. 1A). Two separate G418-resistant clones of N18 cells
transfected with vector without cDNA were chosen as controls.
Extraction of the transfected cells with detergent and analysis
using HB-GAM affinity chromatography showed that binding of
the transfected N-syndecan to HB-GAM was similar to the bind-
ing of the endogenous protein (13) in that it was reversed at about
0.5 M NaCl. The core protein size of about 120 kDa was detected
for the transfected N-syndecan (Fig. 1B), as was previously found
for the brain N-syndecan (13). The intensity of the 120-kDa core
protein band was 2.5-fold higher in the clone (II/7) found to
express N-syndecan at a higher level in Northern blotting as
compared with the clone having a lower expression level (II/8).
N18 neuroblastoma cells can be induced to differentiate into
neuron-like cells by serum starvation (31). They respond
strongly to extracellular matrix molecules such as laminin and
fibronectin by spreading and growing processes. On HB-GAM,
they spread poorly and grow only very few processes. N18 cells
express very little, if any, N-syndecan (Fig. 1).
To study the effect of N-syndecan expression on neurite
growth, the parental cell line and the mock-transfected and the
N-syndecan-transfected cell lines were grown for 24 h on HB-
GAM-coated surfaces. Phase contrast microscopy revealed an
obvious difference in the N-syndecan-transfected cells as com-
pared with the nontransfected or mock-transfected cells. In
particular, the transfected cells with a higher N-syndecan ex-
pression level grew long neurites extending several diameters
of the cell soma (Fig. 2). Most of the neurite-extending cells
were mono- or bipolar. The N-syndecan-expressing clones had
approximately three and nine times more neurite-bearing cells
as compared with the parental and mock-transfected cells
(Figs. 2 and 3), depending on the level of N-syndecan expres-
sion. The number of adherent cells after the 24-h culture did
not vary between clones (not shown).
As neurite growth is known to be regulated by phosphoryl-
ation, effect of the tyrosine kinase inhibitor herbimycin A on
N18 cells was tested. Herbimycin A at the concentration of 1 mM
had no effect on the proportion of neurite-bearing cells in pa-
rental and vector-transfected cells but reduced HB-GAM-
induced neurite outgrowth in N-syndecan expressing clones
almost to the background level (Fig. 3). As biochemical exper-
iments suggested that Src-kinase(s) interact with N-syndecan
(see below), a selective inhibitor of the Src family kinases (PP1;
Ref. 32) was also tested. PP1 also inhibited N-syndecan-de-
pendent neurite outgrowth virtually completely (Fig. 3).
N-syndecan Distributes to Growth Cones and Their Filopo-
dia—To evaluate N-syndecan expression at the plasma mem-
brane level, N-syndecan was immunostained in different cell
clones using affinity-purified anti-peptide antibodies that bind
FIG. 1. Expression of N-syndecan in transfected N18 cells. A,
Northern blot analysis of parental N18 cells (wt), mock-transfected cells
(I/1 and I/2), and N-syndecan-transfected cells (II/8 and II/7). 20 mg of
total RNA was loaded per lane. Ethidium bromide staining detected an
equal amount of RNA on each lane. The transfected cell lines express
mRNA of the expected size, whereas no expression of an endogenous
N-syndecan mRNA can be detected (clones wt, I/1, and I/2). B, Western
blotting of N-syndecan extracted from the parental cells and from the
N-syndecan transfected cells. N-syndecan was bound to the HB-GAM
affinity column, eluted with 0.5 M NaCl and deglycosylated by nitrous
acid treatment prior to Western blotting. Affinity-purified anti-peptide
antibodies detect the core protein of about 120 kDa in the transfected
cells, whereas little, if any, expression is observed in the parental cells
(see also Fig. 4).
FIG. 2. Phase contrast micrographs of N18-cells. Parental N18
cells (A), clone II/8 (B), and clone II/7 (C) were grown on HB-GAM-
coated coverslips for 24 h in serum-free medium. Scale bar, 100 mm.
FIG. 3. Neurite outgrowth in the different cell clones on HB-
GAM-coated matrix in the absence and presence of tyrosine
kinase inhibitors. Proportions of neurite-bearing cells in parental
(wt), mock-transfected (I/1 and I/2), and N-syndecan-transfected (II/8
and II/7) clones were measured. Cells were grown for 24 h on HB-GAM-
coated culture wells (black bars). Neurite outgrowth in the N-syndecan-
transfected clones is inhibited by 1 mM herbimycin A (gray bars) and by
1 mM PP1 (white bars). The data represent mean values (1S.E.) from
four independent experiments (black bars) and mean values (1S.E.)
from three independent experiments for inhibition assays (gray and
white bars).
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to the N-terminal sequence of the core protein. The expression
level of N-syndecan at the cell surface apparently correlated to
the expression level detected by Northern blotting (compare
Figs. 1 and 4). N-syndecan was detected in the cell body and in
neurites, especially in growth cones and in filopodia (Fig. 4).
Kinase Activity and Its Substrate(s) Bind Specifically to the
Cytosolic Moiety of N-syndecan—To detect possible kinase ac-
tivity that binds to N-syndecan, crude extracts of postnatal rat
brain were analyzed using an affinity column to which the
cytosolic moiety of N-syndecan had been coupled (Fig. 5A). The
affinity column was extensively washed, after which the com-
ponents binding specifically to the column were displaced using
the cytosolic peptide in the elution buffer. An intrinsic kinase
activity was consistently detected in the fractions displaced
from the column by the free peptide (Fig. 5A). The activity
remained bound to the column that was washed from a phys-
iological to a somewhat higher salt (0.3 M) concentration but
was displaced by the free peptide in a buffer containing phys-
iological salt. Some remaining activity was eluted from the
column by a high salt concentration (Fig. 5A).
The major phosphorylated component in the N-syndecan-
binding, kinase-active fractions migrated at 80 kDa on SDS-
PAGE (Fig. 5A). As Src family tyrosine kinases occur in the
same fractions (see below), this phosphorylated band might be
due to cortactin (p80/85) that has been identified as a major
substrate of pp60src (33). Immunoprecipitation experiments re-
vealed that cortactin indeed is the major phosphorylated compo-
nent in the fractions containing intrinsic kinase activity (Fig. 5B).
These results suggest that a kinase activity, together with its
substrate(s), associates with the cytosolic domain of N-syndecan.
Src and Fyn Tyrosine Kinases Associate with N-syndecan
Cytosolic Tail—The HB-GAM-induced neurite outgrowth from
N-syndecan-transfected N18 cells was inhibited by herbimycin
and PP1 (see above). This suggests involvement of tyrosine
kinase(s) in the N-syndecan-mediated neurite growth. The ma-
jor non-receptor tyrosine kinases of the growth cones (where
N-syndecan is expected to mediate neurite growth (see above))
belong to the Src family kinases (34, 35). Western blotting of
the fractions that bind to the cytosolic moiety of N-syndecan
detected both c-Src and Fyn in the kinase-active fractions (Fig.
6). Both c-Src and Fyn peak in the fractions eluting with the
peptide, but their interaction with the affinity column can be
partially reversed already at 0.3 M NaCl (Fig. 6). The substrate
sites of the kinases thus seem to bind more tightly to the
affinity column because in the intrinsic kinase assay the activ-
ity associates more rigorously to the fractions that are dis-
placed by the N-syndecan peptide (compare with Fig. 5A).
Tubulin, Cortactin, and a 30-kDa Protein Are Major Compo-
nents Binding to the Cytosolic Moiety of N-syndecan—Coomas-
sie Blue staining of the fractions binding specifically to the
affinity column detected consistently three major proteins. A
major protein migrating at about 50 kDa on SDS-PAGE, a
doublet migrating at about 30 kDa, and an 80-kDa protein
eluted specifically with the peptide (Fig. 7). Sequences of en-
doproteinase Lys-C peptides from the 50-kDa protein were
read as EDAANNYARGHYTIGK, EIIDLVLDRIRK, and GHY-
TEGAELVDSVLDVVK, and they match accurately with the
amino acid sequences of rat a- and b-tubulin (36, 37). The two
different tubulin sequences indicate that both a- and b-tubulin
FIG. 6. Src family kinases associate with N-syndecan. The pep-
tide affinity fractions were immunoblotted with anti-Src (GD11) and
anti-Fyn (Fyn-15) antibodies, followed by horseradish peroxidase-con-
jugated secondary antibodies, and detected with ECL.
FIG. 4. Localization of N-syndecan in N18 cells grown on HB-
GAM matrix. Parental N18 cells (A), clone II/8 cells (B), and clone II/7
(C) cells were stained with affinity-purified anti-peptide antibodies
against N-syndecan (5 mg/ml). Staining is seen in the transfected cells
(B and C) in the cell soma and in neurites. Staining in the neurites is
localized to growth cone and filopodia. Parental cells (A) show faint
staining, which is probably nonspecific. Scale bar, 20 mm.
FIG. 5. Kinase activity and its substrate bind to the cytosolic
moiety of N-syndecan. A, N-syndecan cytosolic peptide coupled to
Sepharose (2 mg of peptide/ml of affinity matrix) was used as a peptide
affinity column. Crude rat brain (postnatal days 4–6) extract was
fractionated using the affinity column and eluted with increasing mo-
larity of NaCl (lanes 1 and 2), followed by elution with the full-length
cytosolic peptide (1 mg/ml) in physiological NaCl (lanes 3–5). 2 mCi of
[g-32P]ATP was added to the affinity fractions in kinase buffer and
incubated at 30 °C for 10 min, and the fractions were subjected to
gradient SDS-PAGE and autoradiography. B, an aliquot of the kinase
activity reaction shown on lane 4 was immunoprecipitated with anti-
cortactin antibodies (4F11).
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are present in the complex associating with N-syndecan. A
monoclonal antibody against the neuron-specific, class III b-tu-
bulin also identified this band in Western blotting (not shown).
It is noteworthy that the 50-kDa band corresponding to tubulin
in protein staining (Fig. 7) and in immunoblotting elutes spe-
cifically with the peptide, whereas the 43-kDa actin band de-
tected by protein staining (Fig. 7) and by immunostaining (not
shown) elutes nonspecifically in all fractions.
The 30-kDa protein could not be identified by peptide mass
fingerprinting (38), suggesting that the sequence of this protein
is not available in the databases searched. The 80-kDa protein
was identified as cortactin by immunoprecipitation from the
kinase assay and by Western blotting with monoclonal anti-
body 4F11 (see above and Fig. 8).
Displacement of the binding components from the affinity
column was also tested using a membrane proximal cytosolic
peptide (RMKKKDEGSYC; NS-2), a polypeptide region that
has the same sequence in all known syndecans. This peptide
eluted the same set of binding components as effectively as the
full-length cytosolic peptide (shown for cortactin in Fig. 8B).
RAGE, an immunoglobulin superfamily member, mediates
neurite outgrowth (39) and binds an overlapping, though a
distinct set of proteins when used as an affinity matrix in the
same way as the N-syndecan cytosolic peptide.2 Experiments
were therefore carried out to elute the N-syndecan-binding
components using the full-length cytosolic peptide of RAGE.
This peptide did not elute any of the components binding to the
N-syndecan peptide (shown for cortactin in Fig. 8B).
C-Src, Cortactin, and Tubulin Copurify with N-syndecan
from Brain Tissue—To study the association of c-Src, cortactin,
and tubulin with N-syndecan in tissue, detergent extracts of
rat brain were passed through an HB-GAM affinity column.
After extensive washing, the affinity column was eluted with a
linear NaCl gradient. The elution patterns of c-Src, cortactin,
and tubulin partially overlapped with the N-syndecan elution
pattern (Fig. 9). The binding of cortactin, tubulin, and c-Src to
N-syndecan seems to be slightly weaker than that of N-synde-
can to HB-GAM, as association of cortactin, c-Src, and tubulin
to the column was reversed with a slightly lower NaCl concen-
tration (0.3–0.6 M for cortactin and Src, and 0.3–0.5 M for
tubulin) than the binding of N-syndecan (0.45–0.7 M). Co-elu-
tion of cortactin and tubulin with c-Src thus agrees with the
prior findings that both of these proteins are co-immunopre-
cipitated with c-Src from cells (40, 41).
Phosphorylation of c-Src and Cortactin Is Enhanced in N-
syndecan-transfected N18 Cells upon Growth on HB-GAM—
The effect of HB-GAM on phosphorylation of Src kinases and
their substrates was studied using N-syndecan-transfected
N18 cells and mock-transfected cells. The N-syndecan-trans-
fected (II/7) and the vector-transfected (I/2) cells were grown on
an HB-GAM matrix for various time periods, after which the
cells were lysed and immunoprecipitated with anti-phosphoty-
rosine agarose. The precipitated materials were subjected to
Western blotting with c-Src and cortactin antibodies. C-Src and
cortactin phosphorylation was repeatedly enhanced upon inter-
action of N-syndecan-transfected N18 cells with an HB-GAM-
coated matrix (Fig. 10). The increase in c-Src phosphorylation
reached its maximum by 20 min, decreasing gradually to 60
min in culture on HB-GAM. Cortactin phosphorylation was
also enhanced in transfected N18 cells, following that of c-Src
and remaining increased up to 40 min of cells in culture on
HB-GAM (Fig. 10A). This suggests that c-Src phosphorylation
in the N-syndecan-transfected N18 cells activates the Src ki-
nase with the consequence of cortactin phosphorylation. In
contrast to the N-syndecan-transfected cells, only a slight
change in phosphorylation of c-Src and cortactin was observed
in mock-transfected cells. Direct Western blotting of the cell
lysates showed that the expression levels of c-Src and cortactin
did not change significantly in the experiments (data not shown).
Increase of cortactin and Src phosphorylation in N-syndecan
transfected cells is hardly a result of overexpression, as the
expression level of N-syndecan in the transfected cells is actually
lower than in brain cells,3 and the same effect is also seen in C6
rat glioma cells, which express endogenous N-syndecan.3
2 H. Huttunen and H. Rauvala, unpublished results. 3 T. Kinnunen and H. Rauvala, unpublished results.
FIG. 7. Proteins that bind specifically to the N-syndecan cyto-
plasmic moiety. The peptide affinity column was eluted as in Fig. 5.
After elution with the cytosolic peptide, the column was further washed
with 1 and 2 M NaCl. Lane 1, total brain extract applied to the column.
Lanes 2 and 3, elution with increasing molarity of NaCl. Lanes 4–6,
elution of the column with the cytosolic peptide. Lanes 7 and 8, elution
with 1 and 2 M NaCl, respectively. Proteins were separated on 10–20%
SDS-PAGE and visualized by Coomassie Blue. The 43-kDa component
that elutes nonspecifically to all fractions is due to actin.
FIG. 8. Cortactin elutes from the affinity column specifically
with the N-syndecan peptide. A, crude rat brain extract was frac-
tionated using the peptide affinity column as in Figs. 5–7. The column
was eluted with the full-length cytoplasmic peptide (NS-1), and frac-
tions were immunoblotted with monoclonal anti-cortactin antibody,
4F11. B, cortactin eluted from the peptide affinity column also with a
peptide corresponding to the membrane proximal domain of syndecan
(NS-2), whereas rat RAGE cytoplasmic peptide (R-1) did not elute
cortactin from the syndecan column. Lanes 1 and 2 in B correspond to
lane 4 in A.
FIG. 9. Association of c-Src and cortactin with N-syndecan in
tissue. Crude extract of rat brain was passed through the HB-GAM
affinity column that was eluted with a linear NaCl gradient. The
affinity fractions were immunoblotted with polyclonal anti-N-syndecan
and anti-Src (SRC-2) antibodies and monoclonal anti-cortactin (4F11)
and class III b-tubulin (SDL.3DID) antibodies.
N-Syndecan in Cell Signaling10706
DISCUSSION
Previous studies have demonstrated that N-syndecan acts as
a receptor or a coreceptor in HB-GAM-induced neurite out-
growth in perinatal rat brain neurons (13–15). The present
results show that N-syndecan, stably transfected to N18 neu-
roblastoma cells, clearly enhances neurite outgrowth upon cell
contact with HB-GAM-containing substrate. This effect can
hardly be explained by increased adhesiveness only, as the
neurite outgrowth response in the cell type used does not
display any direct relationship to adhesiveness of the substrate.
This was previously demonstrated by studying the neurite out-
growth response in N18 cells on many different substrates with
varying degrees of adhesiveness (28). The finding that the tyro-
sine kinase inhibitors herbimycin and PP1 inhibit neurite out-
growth in N-syndecan-transfected cells suggests that the trans-
fection indeed influences a signal transduction pathway.
If N-syndecan is coupled to a tyrosine kinase pathway in
cells, biochemical evidence of such a pathway should be pro-
vided. To this end, we have studied interactions of the cytosolic
moiety of N-syndecan with proteins in crude extracts of peri-
natal brain and cultured cells. The cytosolic moiety of N-syn-
decan and of other syndecans is a reasonable candidate to
interact with cytosolic signal transduction pathway(s) because
it is highly conserved across different syndecans and across
different species in a given syndecan (17–20).
Interestingly, the cytosolic domain of N-syndecan immobi-
lized to an affinity column binds from crude extracts a phos-
phorylating activity containing both kinase(s) and its sub-
strate(s). Displacement of this intrinsic kinase activity from the
affinity column by the free cytosolic peptide in solution indi-
cates that binding of this protein complex to N-syndecan is
specific. Because only the cytosolic moiety of N-syndecan was
used in the experiments, the activity is expected to be due to
nonreceptor cytosolic kinase(s). We suspected that the activity
might be due to Src family tyrosine kinase(s) that are the major
nonreceptor tyrosine kinases in the growth cones of neurons
(34), where N-syndecan is localized and where it is expected to
interact with a kinase pathway to mediate neurite growth.
Furthermore, the Src family kinases have been implicated in
several studies in the regulation of the cytoskeleton during cell
motility phenomena and during adhesion-related signaling in
general (for a review, see Ref. 42). Western blotting using a set
of monoclonal antibodies indeed demonstrated the presence of
both c-Src and Fyn in the kinase-active fractions that bind to
N-syndecan.
The major component that was phosphorylated by the intrin-
sic kinase activity in the fractions that bind to the cytosolic tail
of N-syndecan migrated on SDS-PAGE as an 80-kDa compo-
nent. If the intrinsic kinase activity is due to Src family ki-
nase(s), this component is likely to be cortactin (p80/85), a
filamentous (F) actin-binding protein that was initially identi-
fied as the major phosphorylated protein in Src-transformed
cells (33). In agreement with this premise, monoclonal anti-
cortactin antibodies immunoprecipitated the 80-kDa protein
phosphorylated by the intrinsic kinase activity; in addition,
cortactin was detected by Western blotting in the N-syndecan-
binding fractions. Cortactin was also detected in fractions
eluted with a peptide corresponding to the membrane proximal
region of the syndecan cytoplasmic domain but not in the
fractions eluted with a peptide corresponding to RAGE cyto-
plasmic domain, indicating that the binding is specific. The
occurrence of cortactin in the signal transduction pathway that
connects to N-syndecan is in agreement with the suggested role
of N-syndecan as a neurite growth receptor, as recent genetic
studies using mouse embryos suggest that Src plays a biologi-
cal role in the regulation of cytoskeletal structures via phos-
phorylation of cortactin (43). Cortactin is known to co-immu-
noprecipitate with Src (40) and is localized at the leading edge
of motile fibroblasts where actin undergoes dynamic reorgani-
zation (44, 45). Consistent with the suggested role in the lead-
ing edge function is the observation that cortactin is also con-
centrated in the developing neuromuscular synapses (46) and
in the growth cones of developing rat brain neurons.4
Three major polypeptides were consistently identified by
protein staining in the N-syndecan-binding fractions that were
displaced from the affinity column by the free cytosolic peptide:
a doublet migrating at 30 kDa, a 50-kDa band, and an 80-kDa
band that is due to cortactin (see above). The 30-kDa compo-
nent has not yet been isolated in amounts sufficient for se-
quencing studies. However, the amounts isolated were suffi-
cient for peptide-mass fingerprinting, but screening of the
peptide masses from the 30-kDa band against a data base
containing fragments from over 50,000 proteins (38) did not
identify this polypeptide. The 30-kDa polypeptide may thus be
a novel component, and further studies are required to identify
and characterize this protein.
Peptide sequencing showed that the 50-kDa band is due to a-
and b-tubulins. Tubulin could not be eluted from the protein
complex by extensive washing of the column, and it co-eluted
with cortactin and Src when the full-length cytosolic peptide or
its membrane proximal region were used to displace the pro-
tein complex from the affinity column. It therefore seems that
tubulin is an intrinsic component in the protein complex bind-
ing to N-syndecan. The finding that tubulin, but not actin,
occurs in the protein complex in the isolation method used is
unexpected because microtubules are generally regarded as
components of the central region of the growth cone, whereas
the actin-containing cytoskeleton lines the plasma membrane.
However, a fraction of tubulins is known to associate with the
plasma membrane in the growth cones and to serve as a major
Src substrate in developing neurons (47). In cells, c-Src has
been shown to associate with tubulin by co-immunoprecipita-
tion and by biochemical methods (41). Recent studies have
indicated a regulatory role for tubulin in actin-based growth
and guidance of neurites (48, 49). Microtubules have been
shown to extend to the filopodia (50, 51), where N-syndecan is
also localized. Furthermore, we have very recently found, using
the antibodies that were also used in the present study, that
N-syndecan and tubulin closely colocalize in early axon path-
ways of brain (52). On this basis, we have suggested that
N-syndecan and class III b-tubulin interact during early path-
way formation in tissue (52).
It seems probable that all components that were found to
bind to the cytosolic moiety of N-syndecan, including the Src
family kinases Src and Fyn, cortactin, tubulin, and the 30-kDa
4 M. Kaksonen and H. Rauvala, unpublished results.
FIG. 10. Ligation of N-syndecan by HB-GAM enhances phos-
phorylation of c-Src and cortactin. N-syndecan-transfected (clone
II/7) and mock-transfected (clone I/2) cells were grown on HB-GAM for
the time periods indicated. The cell lysates were immunoprecipitated
with anti-phosphotyrosine agarose and immunoblotted with anti-cor-
tactin (A) and anti-Src (GD11) (B) antibodies.
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protein, do not bind directly but through linking protein(s) that
makes a direct contact with N-syndecan. In agreement with
this idea, binding only to the 30-kDa polypeptide was observed
when the peptide affinity fractions were separated by SDS-
PAGE and analyzed by overlaying with a labeled cytosolic
peptide of N-syndecan.3 Very recently, syntenin, a member of
the PDZ protein superfamily, was shown to bind to the cyto-
plasmic C-terminal domain of syndecan by yeast two-hybrid
screens and by ligand-overlay assay (53). Syntenin may thus
function as an adaptor that couples syndecan to the cytoskel-
eton or cytoplasmic signaling proteins. However, further work
is clearly warranted to understand the molecular organization
of the components bound by the cytosolic moiety of N-syndecan.
For syndecan to be considered as a signaling receptor, it is
necessary to show that the molecular complex associated with
the cytosolic domain undergoes ligand-induced changes in
cells. Interestingly, HB-GAM causes a transient increase in
c-Src phosphorylation in the N-syndecan-transfected cells but
not in the mock-transfected cells. It seems probable that the
N-syndecan-dependent increase in Src phosphorylation also
increases Src activity in cells, as a rise in the level of phospho-
rylation of the major Src substrate, cortactin, temporally par-
allels and follows the Src phosphorylation.
Asundi and Carey (54) have recently shown that N-syndecan
resembles other transmembrane receptors in its ability to self-
associate to dimeric and oligomeric forms in the plasma mem-
brane. The spontaneously occurring self-association was shown
to depend on a structural motif in the transmembrane and
ectodomain flanking regions and to bear some resemblance to
the self-association motif found in the platelet-derived growth
factor receptor (PDGFR-B) and in b3 integrin (54). Although
the functional consequences of the N-syndecan self-association
still remain unclear, it is tempting to speculate that this prop-
erty is essential for the signaling property of N-syndecan ob-
served in this study. In any case, a transmembrane configura-
tion of N-syndecan is required for neurite outgrowth; soluble
extracellular N-syndecan is actually inhibitory in neurite out-
growth (15). Further studies are in progress to elucidate the
sequences in the ectodomain, transmembrane, and cytosolic do-
mains that are required for signaling to the Src-cortactin path-
way during process extension in neurons and in other cells.
Proteoglycans are generally regarded as storage sites for
growth factors or as coreceptors in growth factor signaling but
have not been considered as transmembrane receptors that
would directly interact with cytosolic signaling pathways. How-
ever, syndecan-4, but not other members in the syndecan fam-
ily, has been shown to localize to focal contacts of fibroblasts
(22), suggesting a role in adhesion-dependent cell signaling.
Recent studies (55, 56) have suggested that the cytosolic moiety
of syndecan-4 binds and activates protein kinase C. This activ-
ity seems to be specific for syndecan-4 and was suggested to be
due to the unique central portion in the cytosolic moiety of
syndecan-4 (55). Because the cytosolic moiety in the syndecan
family is highly conserved, one might expect that many, if not
all, syndecan forms would also signal via a common cytosolic
kinase pathway. The present finding that the conserved mem-
brane proximal peptide is as active as the full-length peptide in
displacing the signaling complex from N-syndecan suggests
that also other syndecans may interact with the cortactin-Src
kinase pathway.
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